ANI Pharmaceuticals
ANIP
ANIP
175 hedge funds and large institutions have $369M invested in ANI Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 55 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less capital invested
Capital invested by funds: $422M → $369M (-$52.7M)
28% less call options, than puts
Call options by funds: $8.14M | Put options by funds: $11.4M
Holders
175
Holding in Top 10
–
Calls
$8.14M
Puts
$11.4M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$2.74M | |
| 3 | +$2.58M | |
| 4 |
AIA
Avalon Investment & Advisory
Houston,
Texas
|
+$2.57M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.49M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$3.96M | |
| 3 | -$3.62M | |
| 4 |
Renaissance Technologies
New York
|
-$3.35M |
| 5 |
NC
Nexthera Capital
New York
|
-$2.7M |